193 related articles for article (PubMed ID: 11574201)
1. Diffuse panbronchiolitis--pathophysiology and treatment mechanisms.
Yanagihara K; Kadoto J; Kohno S
Int J Antimicrob Agents; 2001; 18 Suppl 1():S83-7. PubMed ID: 11574201
[TBL] [Abstract][Full Text] [Related]
2. Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Hiratsuka T; Mukae H; Iiboshi H; Ashitani J; Nabeshima K; Minematsu T; Chino N; Ihi T; Kohno S; Nakazato M
Thorax; 2003 May; 58(5):425-30. PubMed ID: 12728165
[TBL] [Abstract][Full Text] [Related]
3. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.
Fujii T; Kadota J; Kawakami K; Iida K; Shirai R; Kaseda M; Kawamoto S; Kohno S
Thorax; 1995 Dec; 50(12):1246-52. PubMed ID: 8553295
[TBL] [Abstract][Full Text] [Related]
4. Diffuse panbronchiolitis: role of macrolides in therapy.
Keicho N; Kudoh S
Am J Respir Med; 2002; 1(2):119-31. PubMed ID: 14720066
[TBL] [Abstract][Full Text] [Related]
5. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
Kobayashi H
Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
[TBL] [Abstract][Full Text] [Related]
6. Diffuse panbronchiolitis.
Poletti V; Chilosi M; Casoni G; Colby TV
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):94-104. PubMed ID: 15281430
[TBL] [Abstract][Full Text] [Related]
7. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection.
Yanagihara K; Tomono K; Sawai T; Hirakata Y; Kadota J; Koga H; Tashiro T; Kohno S
Am J Respir Crit Care Med; 1997 Jan; 155(1):337-42. PubMed ID: 9001333
[TBL] [Abstract][Full Text] [Related]
8. New approaches to Pseudomonas aeruginosa lower respiratory tract infections.
Matsumoto K
Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853
[TBL] [Abstract][Full Text] [Related]
9. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors.
Tateda K; Standiford TJ; Pechere JC; Yamaguchi K
Curr Pharm Des; 2004; 10(25):3055-65. PubMed ID: 15544497
[TBL] [Abstract][Full Text] [Related]
10. Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa.
Yanagihara K; Tomono K; Kuroki M; Kaneko Y; Sawai T; Ohno H; Miyazaki Y; Higashiyama Y; Maesaki S; Kadota J; Kohno S
Clin Exp Immunol; 2000 Oct; 122(1):67-71. PubMed ID: 11012620
[TBL] [Abstract][Full Text] [Related]
11. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.
Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K
Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715
[TBL] [Abstract][Full Text] [Related]
12. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.
Schultz MJ
J Antimicrob Chemother; 2004 Jul; 54(1):21-8. PubMed ID: 15190022
[TBL] [Abstract][Full Text] [Related]
13. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases.
Kudoh S
Am J Med; 2004 Nov; 117 Suppl 9A():12S-19S. PubMed ID: 15586559
[TBL] [Abstract][Full Text] [Related]
14. Diffuse panbronchiolitis.
Poletti V; Casoni G; Chilosi M; Zompatori M
Eur Respir J; 2006 Oct; 28(4):862-71. PubMed ID: 17012632
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis in the setting of idiopathic chronic bronchiolitis with airway colonization from P. aeruginosa: treatment with low-dose macrolides.
Trisolini R; Cancellieri A; Paioli D; Burzi M; Orlandi P; Patelli M
Intern Med; 2008; 47(6):537-42. PubMed ID: 18344642
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery?
Tateda K; Ishii Y; Kimura S; Horikawa M; Miyairi S; Yamaguchi K
J Infect Chemother; 2007 Dec; 13(6):357-67. PubMed ID: 18095083
[TBL] [Abstract][Full Text] [Related]
17. Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis.
Kadota J; Mukae H; Mizunoe S; Kishi K; Tokimatsu I; Nagai H; Tomono K; Kohno S; Nasu M
Intern Med; 2005 Mar; 44(3):200-6. PubMed ID: 15805707
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis.
Katoh S; Matsubara Y; Taniguchi H; Fukushima K; Mukae H; Kadota J; Matsukura S; Kohno S
Clin Exp Immunol; 2001 Dec; 126(3):545-50. PubMed ID: 11737075
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.
Rubin BK; Henke MO
Chest; 2004 Feb; 125(2 Suppl):70S-78S. PubMed ID: 14872003
[TBL] [Abstract][Full Text] [Related]
20. [Diffuse panbronchiolitis complicated by thymoma: a case report and a review of literature].
Zhang D; Wang CH; Li Q
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):608-10. PubMed ID: 15498273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
